Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.07 - $0.19 $136 - $370
1,950 New
1,950 $174,000
Q1 2022

Aug 14, 2024

BUY
$3.78 - $4.66 $7,371 - $9,087
1,950 New
1,950 $8.52 Million
Q3 2021

Aug 30, 2024

BUY
$5.76 - $9.95 $2,880 - $4,975
500 Added 38.46%
1,800 $10.8 Million
Q2 2021

Aug 30, 2024

BUY
$4.7 - $16.7 $6,110 - $21,710
1,300 New
1,300 $13.5 Million
Q1 2021

Aug 30, 2024

BUY
$3.79 - $9.78 $4,927 - $12,714
1,300 New
1,300 $9.93 Million

About Nemaura Medical Inc.


  • Ticker NMRD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,102,900
  • Description
  • Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes...
More about NMRD
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.